Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$638.7K
10.44K shares
ROBIN HOWARD W plans to sell 10.44K shares of NEKTAR THERAPEUTICS valued at approximately $638.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2025 | Restricted Stock Vesting Compensation | 2.99K | — |
8/15/2022 | Restricted Stock Vesting Compensation | 1.42K | — |
5/15/2022 | Restricted Stock Vesting Compensation | 1.97K | — |
2/15/2022 | Restricted Stock Vesting Compensation | 1.52K | — |
11/15/2021 | Restricted Stock Vesting Compensation | 1.86K | — |
8/15/2019 | Restricted Stock Vesting Compensation | 1.00 | — |
5/15/2019 | Restricted Stock Vesting Compensation | 1.00 | — |
2/15/2016 | Restricted Stock Vesting Compensation | 231.00 | — |
| Total | 10K | ||
Completed
Units to sell
444.00
Market value
$29.1K
Planned — Approximate Date
Units to sell
10K
Market value
$609.6K
Units
10.44K
Value
$638.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/19/2026 | 444.00 | $29.1K | — | Completed |
| Planned — Approximate Date | ||||
6/16/2026 | 10K | $609.6K | NASDAQ | Planned |
| Total | 10.44K | $638.7K | ||